199 related articles for article (PubMed ID: 22539591)
1. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.
Letouzé E; Rosati R; Komechen H; Doghman M; Marisa L; Flück C; de Krijger RR; van Noesel MM; Mas JC; Pianovski MA; Zambetti GP; Figueiredo BC; Lalli E
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1284-93. PubMed ID: 22539591
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
3. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
4. Analysis of genomic alterations in sporadic adrenocortical lesions. Gain of chromosome 17 is an early event in adrenocortical tumorigenesis.
Zhao J; Speel EJ; Muletta-Feurer S; Rütimann K; Saremaslani P; Roth J; Heitz PU; Komminoth P
Am J Pathol; 1999 Oct; 155(4):1039-45. PubMed ID: 10514385
[TBL] [Abstract][Full Text] [Related]
5. High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.
Rosati R; Cerrato F; Doghman M; Pianovski MA; Parise GA; Custódio G; Zambetti GP; Ribeiro RC; Riccio A; Figueiredo BC; Lalli E
Cancer Genet Cytogenet; 2008 Oct; 186(1):19-24. PubMed ID: 18786438
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways.
Ronchi CL; Leich E; Sbiera S; Weismann D; Rosenwald A; Allolio B; Fassnacht M
Neoplasia; 2012 Mar; 14(3):206-18. PubMed ID: 22496620
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical Tumors in Children With Constitutive Chromosome 11p15 Paternal Uniparental Disomy: Implications for Diagnosis and Treatment.
Pinto EM; Rodriguez-Galindo C; Lam CG; Ruiz RE; Zambetti GP; Ribeiro RC
Front Endocrinol (Lausanne); 2021; 12():756523. PubMed ID: 34803919
[TBL] [Abstract][Full Text] [Related]
8. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
9. Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults.
Almeida MQ; Soares IC; Ribeiro TC; Fragoso MC; Marins LV; Wakamatsu A; Ressio RA; Nishi MY; Jorge AA; Lerario AM; Alves VA; Mendonca BB; Latronico AC
J Clin Endocrinol Metab; 2010 Mar; 95(3):1458-62. PubMed ID: 20080844
[TBL] [Abstract][Full Text] [Related]
10. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of paediatric adrenocortical tumours.
Pinto EM; Chen X; Easton J; Finkelstein D; Liu Z; Pounds S; Rodriguez-Galindo C; Lund TC; Mardis ER; Wilson RK; Boggs K; Yergeau D; Cheng J; Mulder HL; Manne J; Jenkins J; Mastellaro MJ; Figueiredo BC; Dyer MA; Pappo A; Zhang J; Downing JR; Ribeiro RC; Zambetti GP
Nat Commun; 2015 Mar; 6():6302. PubMed ID: 25743702
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers and the pathogenesis of adrenocortical cancer.
Soon PS; McDonald KL; Robinson BG; Sidhu SB
Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
Mastellaro MJ; Seidinger AL; Kang G; Abrahão R; Miranda ECM; Pounds SB; Cardinalli IA; Aguiar SS; Figueiredo BC; Rodriguez-Galindo C; Brandalise SR; Yunes JA; Barros-Filho AA; Ribeiro RC
Cancer; 2017 Aug; 123(16):3150-3158. PubMed ID: 28387921
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of DNA copy number alterations and loss of heterozygosity in intracranial germ cell tumors.
Terashima K; Yu A; Chow WY; Hsu WC; Chen P; Wong S; Hung YS; Suzuki T; Nishikawa R; Matsutani M; Nakamura H; Ng HK; Allen JC; Aldape KD; Su JM; Adesina AM; Leung HC; Man TK; Lau CC
Pediatr Blood Cancer; 2014 Apr; 61(4):593-600. PubMed ID: 24249158
[TBL] [Abstract][Full Text] [Related]
15. TP53 germline mutations in adult patients with adrenocortical carcinoma.
Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
[TBL] [Abstract][Full Text] [Related]
16. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
Faria AM; Almeida MQ
Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of adrenocortical tumors in southern Brazil.
Custódio G; Komechen H; Figueiredo FR; Fachin ND; Pianovski MA; Figueiredo BC
Mol Cell Endocrinol; 2012 Mar; 351(1):44-51. PubMed ID: 22056871
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.
Juhlin CC; Goh G; Healy JM; Fonseca AL; Scholl UI; Stenman A; Kunstman JW; Brown TC; Overton JD; Mane SM; Nelson-Williams C; Bäckdahl M; Suttorp AC; Haase M; Choi M; Schlessinger J; Rimm DL; Höög A; Prasad ML; Korah R; Larsson C; Lifton RP; Carling T
J Clin Endocrinol Metab; 2015 Mar; 100(3):E493-502. PubMed ID: 25490274
[TBL] [Abstract][Full Text] [Related]
19. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.
Beuschlein F; Schulze E; Mora P; Gensheimer HP; Maser-Gluth C; Allolio B; Reincke M
J Clin Endocrinol Metab; 1998 Jul; 83(7):2585-8. PubMed ID: 9661649
[TBL] [Abstract][Full Text] [Related]
20. A common polymorphism in the retinoic acid pathway modifies adrenocortical carcinoma age-dependent incidence.
Surakhy M; Wallace M; Bond E; Grochola LF; Perez H; Di Giovannantonio M; Zhang P; Malkin D; Carter H; Parise IZS; Zambetti G; Komechen H; Paraizo MM; Pagadala MS; Pinto EM; Lalli E; Figueiredo BC; Bond GL
Br J Cancer; 2020 Apr; 122(8):1231-1241. PubMed ID: 32147670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]